An EFSUMB Introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for Quantification of Tumour Perfusion

Dynamic Contrast Enhanced Ultrasound (DCE-US) is an imaging technique that utilizes microbubble contrast agents in diagnostic ultrasound. The EFSUMB guidelines published in 2004, updated in 2008 and 2011 focused on the use of DCE-US, including essential technical requirements, training, investigational procedures and steps, guidance on image interpretation, established and recommended clinical indications and safety considerations. However the quantification of images acquired with ultrasound contrast agents (UCAs) is not discussed in the guidelines. The purpose of this EFSUMB document is to provide some recommendations and descriptions of the quantification of ultrasound images, technical requirements for analysis of time-intensity curves (TICs), methodology for data analysis, and interpretation of the results.

[1]  H. Kauczor,et al.  Quantification of perfusion of liver tissue and metastases using a multivessel model for replenishment kinetics of ultrasound contrast agents. , 2004, Ultrasound in medicine & biology.

[2]  L. Bolondi,et al.  Quantification of enhancement of focal liver lesions during contrast-enhanced ultrasound (CEUS). Analysis of ten selected frames is more simple but as reliable as the analysis of the entire loop for most parameters. , 2012, European journal of radiology.

[3]  K. Zierler Indicator Dilution Methods for Measuring Blood Flow, Volume, and Other Properties of Biological Systems: A Brief History and Memoir , 2000, Annals of Biomedical Engineering.

[4]  N. Holalkere,et al.  Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma. , 2008, The oncologist.

[5]  Jeffry E. Powers,et al.  Nonlinear pulsing schemes for the detection of ultrasound contrast agents , 2008 .

[6]  Christian Greis,et al.  Technology overview: SonoVue (Bracco, Milan). , 2004, European radiology.

[7]  L Barozzi,et al.  The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): Update 2011 on non-hepatic applications , 2011, Ultraschall in der Medizin.

[8]  Riccardo Lencioni,et al.  Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma , 2010, Seminars in liver disease.

[9]  Fabian Kiessling,et al.  Comparison of intermittent-bolus contrast imaging with conventional power Doppler sonography: quantification of tumour perfusion in small animals. , 2003, Ultrasound in medicine & biology.

[10]  A R Jayaweera,et al.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. , 1998, Circulation.

[11]  Linda Chami,et al.  Dynamic contrast-enhanced ultrasonography (DCE-US) and anti-angiogenic treatments. , 2011, Discovery medicine.

[12]  目時 亮,et al.  Quantification of hepatic parenchymal blood flow by contrast ultrasonography with flash-replenishment imaging , 2006 .

[13]  Fabian Kiessling,et al.  A multivessel model describing replenishment kinetics of ultrasound contrast agent for quantification of tissue perfusion. , 2003, Ultrasound in medicine & biology.

[14]  Linda Chami,et al.  Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results. , 2011, Radiology.

[15]  A. Ignee,et al.  Contrast-Enhanced Endoscopic Ultrasound with Low Mechanical Index: A New Technique , 2005, Zeitschrift fur Gastroenterologie.

[16]  C. Dietrich Contrast-enhanced low mechanical index endoscopic ultrasound (CELMI-EUS) , 2009, Endoscopy.

[17]  A Herment,et al.  An automatic respiratory gating method for the improvement of microcirculation evaluation: application to contrast-enhanced ultrasound studies of focal liver lesions , 2011, Physics in medicine and biology.

[18]  M. Okada,et al.  [New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)]. , 2009, Gan to kagaku ryoho. Cancer & chemotherapy.

[19]  Vassilis Sboros,et al.  Indicator dilution models for the quantification of microvascular blood flow with bolus administration of ultrasound contrast agents , 2010, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[20]  Xiaoping Zhou,et al.  A new formalism for the quantification of tissue perfusion by the destruction-replenishment method in contrast ultrasound imaging , 2006, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[21]  T. Edrich,et al.  Cardiac Output Monitoring Using Indicator-Dilution Techniques: Basics, Limits, and Perspectives , 2010, Anesthesia and analgesia.

[22]  M. Averkiou,et al.  Investigation of the relationship of nonlinear backscattered ultrasound intensity with microbubble concentration at low MI. , 2010, Ultrasound in medicine & biology.

[23]  Sarah Parisot,et al.  Estimation of intra-operator variability in perfusion parameter measurements using DCE-US. , 2011, World journal of radiology.

[24]  S. Koscielny,et al.  Metastatic Renal Cell Carcinoma Treated with Sunitinib: Early Evaluation of Treatment Response Using Dynamic Contrast-Enhanced Ultrasonography , 2010, Clinical Cancer Research.

[25]  R. Karshafian,et al.  Quantification of flow using ultrasound and microbubbles: a disruption replenishment model based on physical principles. , 2009, Ultrasound in medicine & biology.

[26]  Linda Chami,et al.  Quantitative functional imaging by Dynamic Contrast Enhanced Ultrasonography (DCE-US) in GIST patients treated with masatinib , 2012, Investigational New Drugs.

[27]  David Cosgrove,et al.  Imaging of perfusion using ultrasound , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[28]  Costas Strouthos,et al.  Quantification of tumor microvascularity with respiratory gated contrast enhanced ultrasound for monitoring therapy. , 2010, Ultrasound in medicine & biology.

[29]  Peter N. Burns,et al.  Dynamic microbubble contrast-enhanced US to measure tumor response to targeted therapy: a proposed clinical protocol with results from renal cell carcinoma patients receiving antiangiogenic therapy. , 2011, Radiology.

[30]  D. Cosgrove,et al.  Contrast Ultrasonography: Necessity of Linear Data Processing for the Quantification of Tumor Vascularization , 2010, Ultraschall in der Medizin.